TGM2 and breast carcinoma: In our quest to determine the significance of elevated tissue transglutaminase 2 (TG2) expression in drug-resistant and metastatic breast cancer cells [5,6], we found that stable expression of TG2 in mammary epithelial cells is associated with EMT.